So it's always so much fun to wake up to this: FDA advisers weigh risks of asthma drugs . WASHINGTON (AP) -- Government health officials Wednesday publicly aired deep differences over the safety of long-acting asthma drugs and called on outside medical and scientific advisers to help settle the issue. Experts from the Food and Drug Administration's safety office are recommending that medications like Advair and Symbicort no longer be used to treat children with asthma because of the risk of... read more
